{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.7","upperLimit":"73.5","value":"29"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"}],"units":"Participants"}],"description":"The progression free survival of patients treated with single agent lenalidomide","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants who were treated with single agent lenalidomide only","id":"OG000","title":"Single Agent"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"First measure at 8 weeks","title":"Single Agent - Median Progressive Free Survival (PFS)","type":"SECONDARY","unitOfMeasure":"months"}